Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating E2086 in adults with Narcolepsy Type 1 has completed, comparing E2086 to placebo and an active comparator.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy Type

Drugs mentioned

• E2086

Snippet

Sponsor: Eisai Inc. | Conditions: Narcolepsy Type 1 (NT1) | Phase 1 | Status: COMPLETED